Get All Access for $5/mo

Walgreens Boots Alliance Gets Bill for $2.7 Billion From the IRS After Tax Audit 'Tis the (tax) season.

By Emily Rella

Opinions expressed by Entrepreneur contributors are their own.

No one is safe from the IRS this tax season — and multi-billion dollar corporation Walgreens just received a hefty audit from the government.

According to a filing with the U.S. Securities and Exchange Commission on February 29, Walgreens Boots Alliance was hit with a $2.7 billion bill by the IRS after audits the agency conducted allegedly found problems with Walgreens' transfer pricing between 2014 and 2017.

"The Company intends to vigorously defend its position on the transfer pricing matter through the IRS's administrative appeals office and, if necessary, judicial proceedings and is confident in its ability to prevail on the merits," the SEC filing said on behalf of Walgreens.

Walgreens Boots Alliance oversees Walgreens in the U.S. and Boots drugstores in the U.K.

"We believe that we will prevail at the conclusion of the audit," a spokesperson for Walgreens told the Chicago Tribune.

Related: Walgreens Unveils New CEO, $1 Billion Cost-Cutting Plan

According to Investopedia, transfer pricing is defined as an "accounting practice that represents the price that one division in a company charges another division for goods and services provided," which is often used to help lower the overall "tax burden of the parent company."

The IRS is seeking additional tax payments, interest, and penalties in its total compensation from Walgreens.

The audit can take between two to seven years to complete, according to Bloomberg.

Related: Walgreens Boots Alliance Exec Vice President: Raise My Taxes

Walgreens Boots Alliance joins other large corporations, including Meta, Apple, and Microsoft that are also facing IRS audits over transfer pricing issues.

Last fall, Walgreens unveiled a plan to reduce costs by $1 billion after reporting a weak fiscal 2023, which resulted in operating losses of $6.9 billion for the year due to opioid-related lawsuits and other litigation issues.

Amid the losses, Walgreens is now unveiling an aggressive cost-cutting plan, including closing 60 of its clinics, Axios reported.

Emily Rella

Senior News Writer

Emily Rella is a Senior News Writer at Entrepreneur.com. Previously, she was an editor at Verizon Media. Her coverage spans features, business, lifestyle, tech, entertainment, and lifestyle. She is a 2015 graduate of Boston College and a Ridgefield, CT native. Find her on Twitter at @EmilyKRella.

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Editor's Pick

Science & Technology

AI Trends That Will Redefine Your Business in 2025 — You Have 46 Days to Prepare!

The AI trends that are set to reshape your business in 2025 are here—and most entrepreneurs aren't even aware of them yet. From AI agents automating workflows to the evolution of search engines, these changes will redefine how you market, create content, and interact with your customers.

Business Ideas

63 Small Business Ideas to Start in 2024

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2024.

Social Media

Creator Economy Survival Guide — How to Turn Short-Form Content into Long-Term Success

Everyone wants to be a creator, but few know how to turn it into a thriving career. From adopting a business-owner mindset to identifying "winning concepts" and monetizing them like a pro, this is your cheat sheet for turning short-form content into long-term success.

Business News

Elon Musk Accuses ChatGPT-Maker OpenAI of Being a 'Market-Paralyzing Gorgon': Lawsuit

In the amended 107-page complaint, Musk says there would have been no OpenAI without him.